Originally published by our sister publication Gastroenterology & Endoscopy News
CHARLOTTE, N.C.—Patients with inflammatory bowel disease can safely continue biologic drugs around the time they receive mRNA COVID-19 vaccination, with no increase in disease flares, according to the prospective, observational PREVENT-COVID study.
“We recommend continuing IBD medications without interruption while receiving mRNA COVID-19 vaccinations,” said lead investigator Kiran Motwani, MD,